This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Osaka University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Masayoshi Fukasawa: Innovator in Monoclonal Antibody Research
Introduction
Masayoshi Fukasawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Masayoshi Fukasawa holds a patent for an anti-claudin-2 monoclonal antibody. The objective of this invention is to provide a monoclonal antibody that recognizes an extracellular region of Claudin-2. This specific binding capability is crucial for advancing therapeutic options in various medical applications. He has 1 patent to his name.
Career Highlights
Fukasawa is affiliated with Osaka University, where he conducts his research and development activities. His work has garnered attention for its potential impact on understanding and treating diseases related to Claudin-2.
Collaborations
Some of his notable coworkers include Masuo Kondoh and Kiyohito Yagi. Their collaborative efforts contribute to the advancement of research in the field of monoclonal antibodies.
Conclusion
Masayoshi Fukasawa's innovative work in monoclonal antibody research exemplifies the importance of scientific inquiry in addressing health issues. His contributions continue to pave the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile